Violence Against Women (VAW)
Conditions
Keywords
Patient Acceptability, Woman Abuse Screening Tool (WAST), Screening Feasibility, Intimate Partner Violence (IPV), Violence Against Women (VAW)
Brief summary
This single-center observational study aims to assess the feasibility of systematically screening for intimate partner violence (IPV) against women in the emergency department of Hôpital Nord-Ouest de Villefranche-sur-Saône. The study utilizes the Woman Abuse Screening Tool (WAST), a self-administered questionnaire, to identify cases of IPV. The primary objective is to evaluate the feasibility and acceptability of implementing this systematic screening within an emergency setting. The study will measure feasibility through factors such as the implementation rate and adherence by healthcare staff, while acceptability will be assessed based on patient participation and response rates. By analyzing these criteria, the study seeks to determine whether IPV screening can be effectively integrated into routine emergency care. The findings are expected to provide insights into potential barriers and facilitators for screening implementation, contributing to improved detection and support strategies for women experiencing domestic violence.
Interventions
OTHERSelf-questionnaire
Self-questionnaire completed in the waiting room of the emergency department, either on paper or online by scanning a QR-code
Sponsors
L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Female 2. Aged 18 years or older 3. Able to read and write French
Exclusion criteria
1. Refusal to participate in the study 2. Neurocognitive disorders, confusion, or psychotic disorders that preclude study participation 3. Severe uncorrected sensory impairment 4. Life-threatening emergency requiring immediate management in the resuscitation area
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of systematic screening using WAST | At the time of outpatient consultation (Day 0) | Assessed by the proportion of eligible women screened with WAST. |
| Acceptability of WAST | At the time of outpatient consultation (Day 0) | Assessed using an acceptability questionnaire completed by healthcare patient |
Countries
France
Contacts
STUDY_CHAIRLUCIE TEYSSIER, GENERAL MEDECINE
Outcome results
None listed